Funded Tech Companies
Aligos Therapeutics
Wondering who provided funding to Aligos Therapeutics? Boxer Capital, Pivotal bioVenture Partners and Wellington Management Company joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Aligos Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Corporate Drive 2nd Floor
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Aligos Therapeutics (Nasdaq: ALGS) discovers targeted antiviral therapies for chronic hepatitis B (CHB), COVID-19, and optimized therapeutics for Nonalcoholic Steatohepatitis (NASH).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/15/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lawrence Blatt
Chief Financial Officer
Lesley Calhoun
Chief Medical Officer
Matthew McClure
Chief Scientific Officer
Julian Symons
President
Leonid Beigelman
VP - General Counsel
Lucinda Quan
Company Investors
- Boxer Capital
- Pivotal bioVenture Partners
- Wellington Management Company
- Logos Capital
- Cormorant Asset Management
- Janus Henderson Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs